Hepatitis C viraemia in HIV-HCV co-infected patients having immune restoration with highly active antiretroviral therapy

被引：61

作者：

Pérez-Olmeda, M

García-Samaniego, J

Soriano, V

机构：

[1] Inst Salud Carlos III, Infect Dis Serv, Hosp Carlos III, Madrid, Spain

[2] Inst Salud Carlos III, Hepatol Unit, Hosp Carlos III, Madrid, Spain

来源：

AIDS | 2000年 / 14卷 / 02期

关键词：

D O I：

10.1097/00002030-200001280-00023

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：212 / 212

页数：1

共 12 条

[1] Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant [J].

Doglio, A ;

Laffont, C ;

Caroli-Bosc, FX ;

Rochet, P ;

Lefebvre, JC .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1567-1569

[2] Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection [J].

Fialaire, P ;

Payan, C ;

Chennebault, JM ;

Loison, J ;

Pichard, E ;

Lunel, P .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :574-575

[3] Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients [J].

Garcia-Samaniego, J ;

Bravo, R ;

Castilla, J ;

Gómez-Cano, M ;

Laguna, F ;

Muñoz, F ;

Soriano, V .

JOURNAL OF HEPATOLOGY, 1998, 28 (03) :526-527

[4] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].

Hammer, SM ;

Squires, KE ;

Hughes, MD ;

Grimes, JM ;

Demeter, LM ;

Currier, JS ;

Eron, JJ ;

Feinberg, JE ;

Balfour, HH ;

Dayton, LR ;

Chodakewitz, JA ;

Fischl, MA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733

[5]

Nolte FS, 1999, ADV CLIN CHEM, V33, P201

[6]

Rockstroh JK, 1998, AIDS, V12, pS42

[7] Hepatotoxicity after introduction of highly active antiretroviral therapy [J].

Rodríguez-Rosado, R ;

García-Samaniego, J ;

Soriano, V .

AIDS, 1998, 12 (10) :1256-1256

[8] Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV [J].

Rutschmann, OT ;

Negro, F ;

Hirschel, B ;

Hadengue, A ;

Anwar, D ;

Perrin, LH .

JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :783-785

[9] Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C [J].

SanchezQuijano, A ;

Andreu, J ;

Gavilan, F ;

Luque, F ;

Abad, MA ;

Soto, B ;

Munoz, J ;

Aznar, JM ;

Leal, M ;

Lissen, E .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (11) :949-953

[10] Management of chronic hepatitis C in HIV-infected patients [J].

Soriano, V ;

Rodríguez-Rosado, R ;

García-Samaniego, J .

AIDS, 1999, 13 (05) :539-546

← 1 2 →